Paroxysmal Af clinical trials

Explore recruiting paroxysmal af clinical trials.

Recruiting paroxysmal af studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Paroxysmal Af trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A perspective multicenter randomized clinical trial for the safety and efficacy of flecainide compared to amiodorone for the conversion of paroxysmal atrial fibrillation in the Emergency Department in patients with coronary disease without residual ischemia and ejection fraction >35% (FLECA-ED)

Greece

Therapeutic confirmatory (Phase III) EU CTIS Study details

Paroxysmal Af trials by city

Paroxysmal Af in Toronto Paroxysmal Af in Vancouver Paroxysmal Af in Montreal Paroxysmal Af in Calgary Paroxysmal Af in Edmonton Paroxysmal Af in Ottawa Paroxysmal Af in Winnipeg Paroxysmal Af in Quebec City Paroxysmal Af in Hamilton Paroxysmal Af in Kitchener Paroxysmal Af in London Paroxysmal Af in Halifax Paroxysmal Af in New York Paroxysmal Af in Los Angeles Paroxysmal Af in Chicago Paroxysmal Af in Houston

Paroxysmal Af clinical trials

Recruiting paroxysmal af studies right now

Full-Avoidance vs. Permissive/Regulated Drinking & Outcomes On Fibrillation

Pulsed Field Ablation Versus Conventional Radiofrequency Catheter Ablation for Repeat PVI in Patients With Paroxysmal AF

Comprehensive LEFt Atrial Appendage Occlusion With Rhythm Restoration

Pulmonary Vein Isolation Strategy of Very High Power Short Duration in Patients With Paroxysmal Atrial Fibrillation

LAA Clipping Versus NOACs to Prevent Stroke in Non-paroxysmal Atrial Fibrillation.

Randomized Controlled Trial- Ablation Strategy for Paroxysmal Atrial Fibrillation - Trigger and Substrate Guided Wide Area Radiofrequency Ablation Compared to Pulsed Field Ablation Pulmonary Vein Isolation

Marshall Vein Ethanol Infusion in Addition to Pulsed Electric Field Ablation Versus Pulsed Electric Field Ablation Alone for Paroxysmal Atrial Fibrillation

Biofeedback Intervention for Paroxysmal Atrial Fibrillation

Feasibility Study of the FARAFLEX Mapping and PFA System

Safety and Performance of the SpherePVI™ Catheter to Treat Paroxysmal Atrial Fibrillation

Quantitative Superior Vena Cava Isolation in Addition to Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation

Smartwatch and External Holter Monitoring to Detect Atrial Fibrillation in Patients With Cryptogenic Stroke

Also recruiting in Europe

A perspective multicenter randomized clinical trial for the safety and efficacy of flecainide compared to amiodorone for the conversion of paroxysmal atrial fibrillation in the Emergency Department in patients with coronary disease without residual ischemia and ejection fraction >35% (FLECA-ED)

Paroxysmal Af trials by city

Other conditions